V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20026427 | 20011241 | 1.56 | 55.5 | Neo-adjuvant (N) | 2013-04-05 | 2013-04-05 | FEC + DOCETAXEL | N | N | 20093157 | FEC + DOCETAXEL |
| 20026428 | 20011242 | 1.53 | 89 | Adjuvant (A) | 2017-12-15 | 2017-12-27 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20093158 | FEC + DOCETAXEL |
| 20026429 | 20071623 | 1.69 | 77.8 | Adjuvant (A) | null | 2014-02-14 | FEC + DOCETAXEL | N | N | 20093167 | FEC + DOCETAXEL |
| 20026430 | 20011243 | 1.64 | 65.7 | Adjuvant (A) | null | 2016-04-08 | FEC + DOCETAXEL | N | N | 20093175 | FEC + DOCETAXEL |
| 20026431 | 20011243 | 1.75 | 88.8 | Adjuvant (A) | 2017-04-17 | 2017-04-17 | FEC + DOCETAXEL | 2 | null | 20093175 | FEC + DOCETAXEL |
| 20026432 | 20011244 | null | null | Adjuvant (A) | 2017-08-11 | 2017-09-09 | FEC 100 + DOCETAXEL | N | N | 20093183 | FEC + DOCETAXEL |
| 20026434 | 20011246 | 1.67 | 100 | Adjuvant (A) | 2015-09-02 | 2015-09-02 | FEC + DOCETAXEL | 02 | null | 20093195 | FEC + DOCETAXEL |
| 20026435 | 20011246 | 1.6 | 60.4 | Adjuvant (A) | 2014-06-09 | 2014-06-11 | FEC + DOCETAXEL | 02 | N | 20093195 | FEC + DOCETAXEL |
| 20026436 | 20011246 | 1.58 | 119 | Adjuvant (A) | 2016-04-14 | 2016-05-01 | FEC + DOCETAXEL | 02 | N | 20093195 | FEC + DOCETAXEL |
| 20026437 | 20011246 | 1.57 | 69 | Adjuvant (A) | 2016-03-30 | 2016-04-15 | FEC + DOCETAXEL | 02 | Y | 20093195 | FEC + DOCETAXEL |
| 20026438 | 20011247 | 1.71 | 52 | Neo-adjuvant (N) | 2015-11-18 | 2015-12-18 | FEC + DOCETAXEL | 02 | N | 20093207 | FEC + DOCETAXEL |
| 20026439 | 20011247 | 1.58 | 103 | Curative (C) | 2014-09-28 | 2014-10-19 | FEC + DOCETAXEL | N | N | 20093207 | FEC + DOCETAXEL |
| 20026440 | 20011248 | 1.52 | 71 | Adjuvant (A) | 2016-02-20 | 2016-02-29 | FEC + DOCETAXEL | 2 | N | 20093210 | FEC + DOCETAXEL |
| 20026441 | 20011249 | 1.61 | 61.45 | Adjuvant (A) | 2015-09-28 | 2015-09-29 | FEC + DOCETAXEL | 2 | N | 20093212 | FEC + DOCETAXEL |
| 20026442 | 20011249 | 1.51 | 72.5 | Adjuvant (A) | 2015-08-30 | 2015-09-04 | FEC + DOCETAXEL | 02 | N | 20093212 | FEC + DOCETAXEL |
| 20026443 | 20011249 | null | null | Adjuvant (A) | 2017-11-06 | 2017-11-21 | FEC 100 + DOCETAXEL | null | null | 20093212 | FEC + DOCETAXEL |
| 20026444 | 20011249 | 1.63 | 89.85 | Adjuvant (A) | 2017-11-18 | 2017-12-12 | FEC + DOCETAXEL | 2 | N | 20093212 | FEC + DOCETAXEL |
| 20026445 | 20011250 | 1.67 | 100 | Adjuvant (A) | 2015-02-06 | 2015-02-11 | FEC + DOCETAXEL | 02 | N | 20093226 | FEC + DOCETAXEL |
| 20026446 | 20011250 | null | 56.6 | Curative (C) | 2013-08-06 | 2013-08-14 | FEC + DOCETAXEL | 02 | N | 20093226 | FEC + DOCETAXEL |
| 20026447 | 20108774 | null | null | Adjuvant (A) | 2017-03-20 | 2017-03-25 | FEC + DOCETAXEL | N | N | 20093232 | FEC + DOCETAXEL |
| 20026448 | 20127884 | 1.63 | 70.6 | Adjuvant (A) | null | 2016-12-14 | FEC + DOCETAXEL | null | null | 20093234 | FEC + DOCETAXEL |
| 20026449 | 20011251 | 1.74 | 118.1 | Adjuvant (A) | 2015-07-21 | 2015-08-06 | FEC + DOCETAXEL | N | N | 20093236 | FEC + DOCETAXEL |
| 20026450 | 20071629 | 1.5 | 96 | Adjuvant (A) | 2017-10-30 | 2017-11-14 | FEC 100 + DOCETAXEL | null | null | 20093237 | FEC + DOCETAXEL |
| 20026451 | 20011252 | 1.62 | 79 | Adjuvant (A) | 2015-04-01 | 2015-04-02 | FEC + DOCETAXEL | N | N | 20093239 | FEC + DOCETAXEL |
| 20026452 | 20011253 | 1.65 | 64.1 | Adjuvant (A) | 2015-06-08 | 2015-06-08 | FEC 100 + DOCETAXEL | 2 | N | 20093241 | FEC + DOCETAXEL |
| 20026453 | 20011253 | 1.65 | 85 | Neo-adjuvant (N) | 2013-12-29 | 2014-01-12 | FEC 100 + DOCETAXEL | N | N | 20093241 | FEC + DOCETAXEL |
| 20026454 | 20011253 | 1.74 | 63 | Not known (9) | 2013-02-23 | 2013-02-25 | FEC + DOCETAXEL | 02 | N | 20093241 | FEC + DOCETAXEL |
| 20026455 | 20011254 | 1.64 | 88 | Adjuvant (A) | 2016-01-28 | 2016-02-05 | FEC + DOCETAXEL | 02 | N | 20093245 | FEC + DOCETAXEL |
| 20026456 | 20011254 | 1.72 | 73.8 | Neo-adjuvant (N) | 2014-02-08 | 2014-02-11 | FEC + DOCETAXEL | 02 | N | 20093245 | FEC + DOCETAXEL |
| 20026457 | 20011254 | 1.6 | null | null | 2014-05-18 | 2014-06-02 | FEC + DOCETAXEL | N | N | 20093245 | FEC + DOCETAXEL |
| 20026458 | 20011255 | 1.78 | 62.95 | Palliative (P) | 2013-07-05 | 2013-08-01 | FEC 100 + DOCETAXEL | N | N | 20093257 | FEC + DOCETAXEL |
| 20026459 | 20011256 | 1.73 | 57.4 | Curative (C) | 2017-12-21 | 2017-12-21 | FEC 100 + DOCETAXEL | 02 | null | 20093258 | FEC + DOCETAXEL |
| 20026460 | 20011256 | 1.56 | 62 | Adjuvant (A) | 2016-03-29 | 2016-04-09 | FEC + DOCETAXEL | 2 | N | 20093258 | FEC + DOCETAXEL |
| 20026461 | 20011256 | 1.6 | 74.9 | Curative (C) | 2016-05-31 | 2016-06-02 | FEC + DOCETAXEL | N | N | 20093258 | FEC + DOCETAXEL |
| 20026462 | 20127885 | 1.53 | 62.1 | Adjuvant (A) | 2013-08-26 | 2013-08-26 | FEC 100 + DOCETAXEL | 2 | N | 20093270 | FEC + DOCETAXEL |
| 20026463 | 20127885 | 1.62 | 60.2 | Adjuvant (A) | 2014-02-05 | 2014-02-06 | FEC + DOCETAXEL | 2 | Y | 20093270 | FEC + DOCETAXEL |
| 20026464 | 20011257 | 1.64 | 81.4 | Neo-adjuvant (N) | 2015-10-26 | 2015-10-26 | FEC + DOCETAXEL | 2 | N | 20093275 | FEC + DOCETAXEL |
| 20026465 | 20011258 | 1.66 | 58 | Adjuvant (A) | 2016-01-11 | 2016-01-19 | FEC + DOCETAXEL | 02 | null | 20093278 | FEC + DOCETAXEL |
| 20026466 | 20011259 | 1.66 | 89.1 | Adjuvant (A) | 2015-11-21 | 2015-11-24 | FEC 100 + DOCETAXEL | 02 | Y | 20093296 | FEC + DOCETAXEL |
| 20026467 | 20011260 | 1.59 | 93.8 | Neo-adjuvant (N) | 2015-05-13 | 2015-05-25 | FEC + DOCETAXEL | N | N | 20093300 | FEC + DOCETAXEL |
| 20026468 | 20011260 | null | null | Adjuvant (A) | 2018-03-29 | 2018-04-20 | FEC 100 + DOCETAXEL | N | N | 20093300 | FEC + DOCETAXEL |
| 20026469 | 20011260 | 1.55 | 85 | Disease modification (D) | 2016-01-06 | 2016-01-06 | FEC + DOCETAXEL | 02 | N | 20093300 | FEC + DOCETAXEL |
| 20026470 | 20011260 | 1.65 | 78.55 | Neo-adjuvant (N) | 2016-04-23 | 2016-05-09 | FEC + DOCETAXEL | null | null | 20093300 | FEC + DOCETAXEL |
| 20026471 | 20011261 | 1.6 | 72.8 | Adjuvant (A) | 2016-01-11 | 2016-01-11 | FEC + DOCETAXEL | 02 | N | 20093312 | FEC + DOCETAXEL |
| 20026472 | 20011261 | 1.6 | 57.6 | Adjuvant (A) | 2013-11-28 | 2013-11-29 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20093312 | FEC + DOCETAXEL |
| 20026473 | 20011262 | 1.54 | 62.8 | Adjuvant (A) | null | 2015-04-22 | FEC + DOCETAXEL | N | N | 20093315 | FEC + DOCETAXEL |
| 20026474 | 20011263 | 1.62 | 84.9 | Adjuvant (A) | 2017-05-21 | 2017-06-05 | FEC 100 + DOCETAXEL | Y | N | 20093319 | FEC + DOCETAXEL |
| 20026475 | 20011264 | 1.57 | 90 | Adjuvant (A) | 2015-09-10 | 2015-09-25 | FEC + DOCETAXEL | N | N | 20093320 | FEC + DOCETAXEL |
| 20026476 | 20011265 | 1.6 | 80 | Adjuvant (A) | 2015-08-15 | 2015-08-27 | FEC + DOCETAXEL | 2 | N | 20093321 | FEC + DOCETAXEL |
| 20026477 | 20011266 | 1.7 | 62.1 | Adjuvant (A) | 2016-02-14 | 2016-02-14 | FEC + DOCETAXEL | N | null | 20093322 | FEC + DOCETAXEL |